1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
| Generic Name |
Common Trade Name(s) |
Classification | Date Marketed in Canada (yyyy/mm/dd) |
|---|---|---|---|
| Cabotegravir | Vocabria | Antiretroviral agent | 2020/03/19 |
| Sofosbuvir + velpatasvir + voxilaprevir | Vosevi | Antiviral agent for treatment of chronic hepatitis C infection | 2017/09/18 |
| Pazopanib | Votrient | Antineoplastic agent | 2011/08/25 |
| Velaglucerase alfa | Vpriv | Enzyme replacement for treatment of Gaucher disease | 2010/11/22 |
| Eptinezumab | Vyepti | Prevention of migraine; calcitonin gene-related peptide binding antibody | 2021/01/11 |
| Imiquimod | Vyloma | Immune response modifier | 2011/05/04 |
| Tafamidis | Vyndaqel | Selective stabilizer of transthyretin - cardiac drug | 2020/04/07 |
| Lisdexamfetamine | Vyvanse | CNS stimulant | 2010/04/20 |
| Crizotinib | Xalkori | ALK Tyrosine Kinase Inhibitor | |
| Telotristat ethyl | Xermelo | Tryptophan hydroxylase inhibitor | 2018/10/12 |
| Denosumab | Xgeva | Bone resorption inhibitor | 2011/10/05 |
| Dapgliflozin + metformin | Xigduo | Sodium-glucose contransporter 2 (SGLT2) inhibitor plus metformin | 2016/02/08 |
| Drotrecogin alfa | Xigris | Antithrombotic profibrinolytic anti-inflammatory enzyme | 2011/10/25 |
| Lifitegrast | Xiidra | Lymphocyte function associated antigen-1 (LFA-1) antagonist | 2017/12/22 |
| Baloxavir marboxil | Xofluza | Antiviral agent | 2020/02/19 |
| Gilteritinib | Xospata | Antineoplastic agent | 2020/02/03 |
| Enzalutamide | Xtandi | Antineoplastic agent | 2013/06/07 |
| Liraglutide + Insulin Degludec | Xultophy | Incretin mimetic + insulin | 2018/06/06 |
| Moroctocog alfa | Xyntha | Hemostatic agent | 2009/01/23 |
| Ipilimumab | Yervoy | Antineoplastic agent | 2012/03 |
| Axicabtagene ciloleucel | Yescarta | Antineoplastic agent | 2019/11/27 |
| Trabectedin | Yondelis | Antineoplastic agent | 2010/08/04 |
| Ceftobiprole medocaril | Zeftera | Cephalosporin antibiotic | 2010/04/16 |
| Niraparib | Zejula | Antineoplastic agent | 2020/01/09 |
| Vemurafenib | Zelboraf | Protein kinase inhibitor | 2012/03/06 |
| Vemurafenib | Zelboraf | Antineoplastic agent | 2012/02 |
| Mometasone + formoterol | Zenhale | Corticosteroid + long-acting beta2- agonist | 2011/02/01 |
| Elbasvir + grazoprevir | Zepatier | Antiviral agent | 2016/02/02 |
| Ceftobiprole | Zevtera | Cephalosporin antibiotic | 2018/03/20 |
| Azithromycin dihydrate | Zmax SR | Antibiotic | 2010/10/29 |
| Onasemnogene | Zolgensma | Cellular and gene therapy | 2021/02/04 |
| Vorinostat | Zolinza | Histone deacetylase inhibitor, anti-neoplastic agent | 2009/06/17 |
| Zoster vaccine | Zostavax | Vaccine | 2009/08/11 |
| Zucapsaicin | Zuacta | Topical agent for joint and muscular pain | 2011/08/24 |
| Abiraterone | Zytiga | Androgen biosynthesis inhibitor | 2011/08/08 |
| Tramadol | Zytram XL | Opioid analgesic | 2011/03/01 |